Topic Editors

Institute of Polymers, Bulgarian Academy of Sciences, Acad. G. Bonchev St. 103-A, 1113 Sofia, Bulgaria
Institute of Polymers, Bulgarian Academy of Sciences, Acad. G. Bonchev St. 103-A, 1113 Sofia, Bulgaria

Applications of Polymers and Polymer Nanomaterials in Drug Delivery and Nanomedicine

Abstract submission deadline
closed (31 March 2024)
Manuscript submission deadline
31 May 2024
Viewed by
5061

Topic Information

Dear Colleagues,

The focus of modern pharmaceutical science is aimed at the possibility for control, extension, sustaining, and targeting of the bioactive compounds. Moreover, the efforts are intended to overcome the limitations of the drugs itself, such as decreasing its toxicity and side effects, its instabilities, and unwanted changes. In the field of drug delivery science, polymers have seen significant progress. They provide the possibility for development of delivery systems of higher hierarchical order owing to their unique properties on a molecular and supramolecular level. Their possibility for improvement of the pharmacokinetic properties of drugs is practically unrestricted. This topics is an attempt to summarize recent progress in the knowledge of drug delivery systems based on hydrogels, micro- and nanosized gels, biodegradable polymers, stimuli-responsive systems, polymer and polymer-hybrd nanoparticles, etc., in the development of alternative formulations and administration routes. The evolution of polymer based delivery systems of large molecules as well as biomolecules also will be addressed.

Prof. Dr. Stanislav Rangelov
Dr. Emi Haladjova
Topic Editors

Keywords

  • biodegradable polymers
  • polymer and polymer-hybrid nanoparticles
  • hydrogels
  • microgels
  • nanopharmaceutics
  • controlled release
  • targeted therapy
  • gene delivery

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Biomedicines
biomedicines
4.7 3.7 2013 15.4 Days CHF 2600 Submit
Journal of Nanotheranostics
jnt
- - 2020 26.8 Days CHF 1000 Submit
Pharmaceutics
pharmaceutics
5.4 6.9 2009 14.2 Days CHF 2900 Submit
Macromol
macromol
- - 2021 34.7 Days CHF 1000 Submit

Preprints.org is a multidiscipline platform providing preprint service that is dedicated to sharing your research from the start and empowering your research journey.

MDPI Topics is cooperating with Preprints.org and has built a direct connection between MDPI journals and Preprints.org. Authors are encouraged to enjoy the benefits by posting a preprint at Preprints.org prior to publication:

  1. Immediately share your ideas ahead of publication and establish your research priority;
  2. Protect your idea from being stolen with this time-stamped preprint article;
  3. Enhance the exposure and impact of your research;
  4. Receive feedback from your peers in advance;
  5. Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (3 papers)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
22 pages, 5470 KiB  
Article
Dually Modified Cellulose as a Non-Viral Vector for the Delivery and Uptake of HDAC3 siRNA
by Juliana Hülsmann, Henry Lindemann, Jamila Wegener, Marie Kühne, Maren Godmann, Andreas Koschella, Sina M. Coldewey, Thomas Heinze and Thorsten Heinzel
Pharmaceutics 2023, 15(12), 2659; https://doi.org/10.3390/pharmaceutics15122659 - 23 Nov 2023
Viewed by 903
Abstract
RNA interference can be applied to different target genes for treating a variety of diseases, but an appropriate delivery system is necessary to ensure the transport of intact siRNAs to the site of action. In this study, cellulose was dually modified to create [...] Read more.
RNA interference can be applied to different target genes for treating a variety of diseases, but an appropriate delivery system is necessary to ensure the transport of intact siRNAs to the site of action. In this study, cellulose was dually modified to create a non-viral vector for HDAC3 short interfering RNA (siRNA) transfer into cells. A guanidinium group introduced positive charges into the cellulose to allow complexation of negatively charged genetic material. Furthermore, a biotin group fixed by a polyethylene glycol (PEG) spacer was attached to the polymer to allow, if required, the binding of targeting ligands. The resulting polyplexes with HDAC3 siRNA had a size below 200 nm and a positive zeta potential of up to 15 mV. For N/P ratio 2 and higher, the polymer could efficiently complex siRNA. Nanoparticles, based on this dually modified derivative, revealed a low cytotoxicity. Only minor effects on the endothelial barrier integrity and a transfection efficiency in HEK293 cells higher than Lipofectamine 2000TM were found. The uptake and release of the polyplexes were confirmed by immunofluorescence imaging. This study indicates that the modified biopolymer is an auspicious biocompatible non-viral vector with biotin as a promising moiety. Full article
Show Figures

Graphical abstract

38 pages, 2567 KiB  
Review
Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems
by Cláudia Viegas, Ana B. Patrício, João Prata, Leonor Fonseca, Ana S. Macedo, Sofia O. D. Duarte and Pedro Fonte
Pharmaceutics 2023, 15(9), 2363; https://doi.org/10.3390/pharmaceutics15092363 - 21 Sep 2023
Viewed by 1884
Abstract
Pancreatic cancer represents one of the most lethal cancer types worldwide, with a 5-year survival rate of less than 5%. Due to the inability to diagnose it promptly and the lack of efficacy of existing treatments, research and development of innovative therapies and [...] Read more.
Pancreatic cancer represents one of the most lethal cancer types worldwide, with a 5-year survival rate of less than 5%. Due to the inability to diagnose it promptly and the lack of efficacy of existing treatments, research and development of innovative therapies and new diagnostics are crucial to increase the survival rate and decrease mortality. Nanomedicine has been gaining importance as an innovative approach for drug delivery and diagnosis, opening new horizons through the implementation of smart nanocarrier systems, which can deliver drugs to the specific tissue or organ at an optimal concentration, enhancing treatment efficacy and reducing systemic toxicity. Varied materials such as lipids, polymers, and inorganic materials have been used to obtain nanoparticles and develop innovative drug delivery systems for pancreatic cancer treatment. In this review, it is discussed the main scientific advances in pancreatic cancer treatment by nano-based drug delivery systems. The advantages and disadvantages of such delivery systems in pancreatic cancer treatment are also addressed. More importantly, the different types of nanocarriers and therapeutic strategies developed so far are scrutinized. Full article
Show Figures

Figure 1

19 pages, 3600 KiB  
Review
Polymeric Theragnostic Nanoplatforms for Bone Tissue Engineering
by Kaushita Banerjee and Harishkumar Madhyastha
J. Nanotheranostics 2023, 4(3), 280-298; https://doi.org/10.3390/jnt4030013 - 20 Jul 2023
Viewed by 1458
Abstract
Nanomaterial-based tissue engineering strategies are precisely designed and tweaked to contest specific patient needs and their end applications. Though theragnostic is a radical term very eminent in cancer prognosis, of late, theragnostic approaches have been explored in the fields of tissue remodulation and [...] Read more.
Nanomaterial-based tissue engineering strategies are precisely designed and tweaked to contest specific patient needs and their end applications. Though theragnostic is a radical term very eminent in cancer prognosis, of late, theragnostic approaches have been explored in the fields of tissue remodulation and reparation. The engineering of theragnostic nanomaterials has opened up avenues for disease diagnosis, imaging, and therapeutic treatments. The instantaneous monitoring of therapeutic strategy is expected to co-deliver imaging and pharmaceutical agents at the same time, and nanoscale carrier moieties are convenient and efficient platforms in theragnostic applications, especially in soft and hard tissue regeneration. Furthermore, imaging modalities have extensively contributed to the signal-to-noise ratio. Simultaneously, there is an accumulation of high concentrations of therapeutic mediators at the defect site. Given the confines of contemporary bone diagnostic systems, the clinical rationale demands nano/biomaterials that can localize to bone-diseased sites to enhance the precision and prognostic value for osteoporosis, non-healing fractures, and/or infections, etc. Furthermore, bone theragnostics may have an even greater clinical impact and multimodal imaging procedures can overcome the restrictions of individual modalities. The present review introduces representative theragnostic polymeric nanomaterials and their advantages and disadvantages in practical use as well as their unique properties. Full article
Show Figures

Figure 1

Back to TopTop